Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: Application of new methodology

  1. Garnett, S.A.
  2. Martin, M.
  3. Jerusalem, G.
  4. Petruzelka, L.
  5. Torres, R.
  6. Bondarenko, I.N.
  7. Khasanov, R.
  8. Verhoeven, D.
  9. Pedrini, J.L.
  10. Smirnova, I.
  11. Lichinitser, M.R.
  12. Pendergrass, K.
  13. Lindemann, J.P.O.
  14. Di Leo, A.
Zeitschrift:
Breast Cancer Research and Treatment

ISSN: 1573-7217 0167-6806

Datum der Publikation: 2013

Ausgabe: 138

Nummer: 1

Seiten: 149-155

Art: Artikel

DOI: 10.1007/S10549-012-2395-8 GOOGLE SCHOLAR lock_openOpen Access editor